Clinical trials · Indiana
Urinary Bladder Neoplasms clinical trials in Indiana
We’re tracking 6 recruiting urinary bladder neoplasms studies with a site in Indiana — including Phase 1 and Phase 3 studies, each written for real people, not researchers.
Recruiting studies in Indiana
- NCT07218380RecruitingPhase 3
Study of Vepugratinib for advanced bladder or urinary tract cancer
This trial tests an experimental drug called Vepugratinib for people with advanced urinary tract cancer that has a specific change in the FGFR3 gene. It may be an option if you haven't had other treatments for advanced cancer and are looking for a new approach.
Fort Wayne, IndianaAges 18 years+ - NCT05614739RecruitingPhase 1
Study drug for cancers with an FGFR3 gene change
This Phase 1 trial tests LOXO-435 in people with solid tumors that have an FGFR3 pathway gene alteration. It may help shrink or control cancer by targeting this specific gene change.
Indianapolis, IndianaAges 18 years+ - NCT04389632RecruitingPhase 1
Sigvotatug vedotin for advanced solid tumors that spread
This early-stage study tests a drug called sigvotatug vedotin in people with advanced solid cancers that cannot be removed or have spread. It aims to see how well the treatment works and what side effects it causes.
Indianapolis, IndianaAges 18 years+ - NCT07566156RecruitingPhase 3
New drug combination vs. radiation for bladder cancer preservation
This trial tests whether two drugs (enfortumab vedotin and pembrolizumab) work better than radiation with chemotherapy for muscle-invasive bladder cancer. The goal is to treat your cancer while keeping your bladder instead of removing it.
Fort Wayne, IndianaAges 18 years+ - NCT06465069RecruitingPhase 1
Study of a new drug for advanced bladder and other solid tumors
This study tests a new drug (LY4052031) for people with several types of advanced solid tumors, especially bladder cancer. It aims to see if the drug is safe and effective when given alone or after other treatments have stopped working.
Indianapolis, IndianaAges 18 years+ - NCT06319820RecruitingPhase 3
TAR-210 vs standard bladder chemo for FGFR-mutated bladder cancer
This trial compares a new drug, TAR-210, which is placed directly into the bladder, against standard chemotherapy given through a catheter. It is for people with a specific type of bladder cancer that has a change in the FGFR gene.
Jeffersonville, IndianaAges 18 years+
Urinary Bladder Neoplasms trials by city in Indiana
Where these studies are running in Indiana
Institutions with a site for the recruiting urinary bladder neoplasms studies listed above.
- Indiana University School of Medicine · 3 studies
- Community Health Network
- First Urology
- Fort Wayne Medical Oncology and Hematology
- Franciscan Health Indianapolis
- Parkview Health
- Parkview Research Center at Parkview Regional Medical Center
- University of Chicago Medicine Northwest Indiana
What taking part in a urinary bladder neoplasms study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Urinary Bladder Neoplasms trials in other states
Common questions
- Are there urinary bladder neoplasms clinical trials in Indiana?
- Yes. We're currently tracking 6 recruiting urinary bladder neoplasms studies with a site in Indiana, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a urinary bladder neoplasms study in Indiana?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Indiana to take part?
- Not necessarily. These studies have a site in Indiana, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a urinary bladder neoplasms trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New urinary bladder neoplasms studies open in Indiana regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.